Cita APA (7a ed.)

Wang, R., Yamada, T., Kita, K., Taniguchi, H., Arai, S., Fukuda, K., . . . Yano, S. (2020). Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer. Nature Portfolio.

Cita Chicago Style (17a ed.)

Wang, Rong, et al. Transient IGF-1R Inhibition Combined with Osimertinib Eradicates AXL-low Expressing EGFR Mutated Lung Cancer. Nature Portfolio, 2020.

Cita MLA (8a ed.)

Wang, Rong, et al. Transient IGF-1R Inhibition Combined with Osimertinib Eradicates AXL-low Expressing EGFR Mutated Lung Cancer. Nature Portfolio, 2020.